SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma | Regional Centre for Biotechnology

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma

SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma

What's New

BET 2025 Results

GAT-B 2025 Result Notice

Admissions to the i3c BRIC-RCB PhD Programme in Biosciences 2025-26

Admission to the PhD Programme in Biotechnology 2025-26 (Monsoon Semester) (Last date extended till 09.06.2025)

List of candidates selected under 7th Call of DBT-BioCARe Program 2024-25

Result of DBT-RA Call II of F.Y. 2024-25

LIST OF PROVISIONALLY SHORTLISTED & NOT SHORTLISTED APPLICANTS FOR THE POSITION OF REGISTRAR, RCB

Previous Pause Next

Accessibility Tools